CHARLOTTESVILLE, Va – November 10, 2026 – Luminoah, a medical technology company modernizing enteral nutrition, today announced a $25 million Series B financing led by Sandbox Clinical Ventures, with participation from the Blue Venture Fund, GV (Google Ventures), Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund, the American Gastroenterological Association GI Opportunity Fund, and existing investors.
The Series B includes $20 million in new equity capital and $5 million in previously issued convertible notes that converted as part of the financing. The new capital will support expanded distribution of Luminoah Flow™, the company’s FDA-cleared enteral feeding system, increased manufacturing capacity, and continued development of Luminoah Intelligence™, its clinician-facing data platform.
Following FDA clearance in April 2026, Luminoah completed an early access program with patients served by leading healthcare institutions in the Pacific Northwest and Southeast.